Human Immunodeficiency Virus Infections Clinical Trial
Official title:
Open-Label Study With Rilpivirine in Treatment-naïve Indian Subjects With HIV-1 Infection to Determine Safety and Efficacy
The primary purpose of the study is to evaluate the efficacy of rilpivirine (RPV)-based regimen in human immunodeficiency virus type 1 (HIV-1) infected, antiretroviral (ARV) treatment-naive participants, as determined by the percentage of virologic responders defined as having HIV-1 ribonucleic acid (RNA) less than 400 copies/ milliliter (mL) at Week 24.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00294918 -
An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome
|
Phase 2/Phase 3 | |
| Completed |
NCT00888446 -
Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid
|
Phase 2 | |
| Completed |
NCT00262522 -
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects
|
Phase 3 | |
| Completed |
NCT00294164 -
Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT00332306 -
Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment
|
Phase 3 | |
| Completed |
NCT00727597 -
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
|
Phase 3 | |
| Completed |
NCT02452242 -
Safety, PK and PD Study of ABX464 in Untreated HIV Patients
|
Phase 2 | |
| Active, not recruiting |
NCT00376012 -
Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis
|
Phase 3 | |
| Completed |
NCT00358917 -
Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects
|
Phase 3 | |
| Completed |
NCT00749840 -
Attitudes and Beliefs and the Steps of HIV Care
|
N/A |